On 2nd May 2019, in Hanoi, Mavin Animal Health Joint Stock Company (Mavin AH) held Customer Meeting 2019. Attending the Meeting were several customers of Mavin AH and the Company’s staff.
On behalf of Mavin Group, Mr. Nguyen Anh Tuan - Deputy General Director of Mavin cum CEO of Mavin AH expressed his gratitude for the companionship of customers, and expressed his desire to continue to receive the support of loyal customers in the future.
At the ceremony, Mavin AH introduced a number of strategic products and upcoming products of the Company. Mavin AH also noted some valuable comments from customers to develop the company in the future.
Veterinary medicine is one of the important links in the supply chain "From Farm to Table" of Mavin Group. In this field, Mavin has invested in Cai Lay Veterinary Pharmaceutical Joint Stock Company (from 2013) and Mavin Animal Health Joint Stock Company (from 2018).
Mavin AH was established to research, produce, import and distribute veterinary medicine products, aquatic drugs, animal nutrition according to WHO-GMP standards. Mavin AH's mission is to provide a comprehensive solution for livestock farmers to prevent and treat livestock diseases, increasing the value of their livestock production.